Specifically, all three genotypes of CYP2E1 at rs3813865 were found to be susceptible to CRC when present with either wild-type (GG) or heterozygous (GC) genotypes at rs1042522 in TP53 (P = 0.04) (Table 2). This evidence concerns the gene CYP2E1 and colorectal carcinoma.